Revisão · Revista · 2026

Gene Editing Therapies for Sickle Cell Disease and β-Thalassemia: A Systematic Review of Clinical Outcomes and Safety

Chidinma Gab-Obinna, Ikemefula Oriaku, Okeoma Obiageri Ihuarulam, Adepeju Kafayat Olowookere, Enobong Edoabasi Obong, Nwamaka Nneka Onyedum e mais 1

Australian Journal of Biomedical Research

• Acesso aberto · Híbrido
• Internacional · 3 países

Lê-lo10.63946/aubiomed/17736